Related content

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

By Jonat Walter   Hilpert Felix  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 6, 2006-06 ,pp. : 343-355

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

By Eggemann Holm  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 465-470

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitors in the treatment of early and advanced breast cancer

By Joensuu Heikki   Ejlertsen Bent   Lønning Per   Rutqvist Lars-Erik  

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Aromatase Inhibitors: Indications for Breast Cancer Therapy

By Assikis V.J.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 93-100

Adis International

Access to resources Recommend Favorite

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite